MECHANISTIC AND PHARMACOLOGICAL DIFFERENTIATION OF ZILUCOPLAN, A MACROCYCLIC PEPTIDE INHIBITOR OF COMPLEMENT COMPONENT 5 (C5), FROM ANTI-C5 MONOCLONAL ANTIBODIES-MedSci.cn

MECHANISTIC AND PHARMACOLOGICAL DIFFERENTIATION OF ZILUCOPLAN, A MACROCYCLIC PEPTIDE INHIBITOR OF COMPLEMENT COMPONENT 5 (C5), FROM ANTI-C5 MONOCLONAL ANTIBODIES

Sayegh, C; Arata, M; DeMarco, S; Duda, P; Farzaneh-Far, R; Ma, Z; Read, S; Ricardo, A; Tang, GQ; Thackaberry, E; Vadysirisack, D; Zhu, NQ

MOLECULAR IMMUNOLOGY, 2019; 114 (): 447

科室
- - 订阅+
  - 更多科室
工具
服务